GlassScriptPhysician profile
Levi J Berry
NPI 1689938748
$3,582.92
in general payments reported to CMS, 2019-2025
17 companies · $506 in 2025
The $506 reported for 2025 was more than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,586 · 2020: $1,070 · 2021: $15.96 · 2023: $103 · 2024: $302 · 2025: $506.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $910.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $910.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Active Medical, LLC | $1,574.09 | 2019-2020 | |
| Stryker Corporation | $1,343.68 | 2019-2025 | Easyfuse, Sonicanchor, Augment Injectable |
| Paratek Pharmaceuticals, INC. | $133.71 | 2024-2025 | Nuzyra |
| Orthofix Medical, INC. | $122.33 | 2023-2025 | Physio-Stim |
| Paragon 28, INC. | $67.83 | 2024-2025 | Mini Monster, Jaws, Grappler |
| Ani Pharmaceuticals, INC. | $55.70 | 2025 | Purified Cortrophin Gel |
| Treace Medical Concepts, INC. | $46.65 | 2024-2025 | |
| Smith+Nephew, INC. | $45.91 | 2024-2025 | Stravix, Grafix Pl |
| Horizon Therapeutics Plc | $30.69 | 2020-2021 | |
| Vertex Pharmaceuticals Incorporated | $27.66 | 2025 | |
| Kowa Pharmaceuticals America, INC. | $26.98 | 2023 | Seglentis |
| Solventum Corporation | $24.32 | 2025 | Activ.A.C., Snap, Promogran Prisma |
| Medtronic, INC. | $20.78 | 2025 | Inceptiv |
| Melinta Therapeutics, LLC | $16.80 | 2019 | |
| Kci USA, INC. | $16.54 | 2023 | Promogran Prisma, Activ.A.C. |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biowound Solutions, INC. | $14.77 | 2025 | Bio-Connekt |
| Baudax Bio INC. | $14.48 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Levi Berry listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.